Storia in 2 fonti

Moving T-DXd Into Earlier HER2-Positive Breast Cancer Care

Jame Abraham, MD, discusses how DESTINY-Breast11 may reshape care

Raccontata da

medpagetoday.com

healio.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

medpagetoday.comStai leggendo1 mese fa

Moving T-DXd Into Earlier HER2-Positive Breast Cancer Care

Jame Abraham, MD, discusses how DESTINY-Breast11 may reshape care

originale

healio.com1 mese fa

VIDEO: Clinicians ‘should continue to pay attention’ to T-DXd side effects in breast cancer

CHICAGO — In this video, Jame Abraham, MD, discusses a secondary safety analysis of the DESTINY-Breast05 study, with particular focus on clinical and demographic risk factors for interstitial lung disease and radiation…

Leggi questa versione → originale

Timeline cronologica

martedì 16 giugno 2026·medpagetoday.com
Moving T-DXd Into Earlier HER2-Positive Breast Cancer Care
Jame Abraham, MD, discusses how DESTINY-Breast11 may reshape care
mercoledì 17 giugno 2026·healio.com
VIDEO: Clinicians ‘should continue to pay attention’ to T-DXd side effects in breast cancer
CHICAGO — In this video, Jame Abraham, MD, discusses a secondary safety analysis of the DESTINY-Breast05 study, with particular focus on clinical and demographic risk factors for…